vs
ASP Isotopes Inc.（ASPI）与Arcus Biosciences, Inc.（RCUS）财务数据对比。点击上方公司名可切换其他公司
ASP Isotopes Inc.的季度营收约是Arcus Biosciences, Inc.的1.5倍（$16.7M vs $11.0M），ASP Isotopes Inc.同比增速更快（1295.7% vs -52.2%），ASP Isotopes Inc.自由现金流更多（$-47.4M vs $-121.0M）
ASP Isotopes Inc.是一家特种材料企业，专注于高纯度定制同位素的研发与生产，产品广泛应用于核医学、靶向抗癌治疗、清洁能源及工业研究等领域，客户覆盖北美、欧洲及亚太地区。
Arcus Biosciences是一家处于临床阶段的美国基因编辑上市企业，总部位于北卡罗来纳州达勒姆，成立于2006年。公司依托其专有的“ARCUS”基因组编辑平台，专注于开发体内及体外基因编辑疗法，为相关疾病治疗提供创新解决方案。
ASPI vs RCUS — 直观对比
营收规模更大
ASPI
是对方的1.5倍
$11.0M
营收增速更快
ASPI
高出1347.9%
-52.2%
自由现金流更多
ASPI
多$73.6M
$-121.0M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $16.7M | $11.0M |
| 净利润 | — | $-106.0M |
| 毛利率 | 12.5% | — |
| 营业利润率 | — | -1036.4% |
| 净利率 | — | -963.6% |
| 营收同比 | 1295.7% | -52.2% |
| 净利润同比 | -586.8% | -12.8% |
| 每股收益（稀释后） | — | $-0.88 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASPIRCUS
| Q4 25 | $16.7M | $11.0M | ||
| Q3 25 | $4.9M | $6.0M | ||
| Q2 25 | — | $8.0M | ||
| Q1 25 | — | $8.0M | ||
| Q4 24 | — | $23.0M | ||
| Q3 24 | — | $7.0M | ||
| Q2 24 | — | $11.0M | ||
| Q1 24 | — | $10.0M |
净利润ASPIRCUS
| Q4 25 | — | $-106.0M | ||
| Q3 25 | $-12.9M | $-135.0M | ||
| Q2 25 | — | $0 | ||
| Q1 25 | — | $-112.0M | ||
| Q4 24 | — | $-94.0M | ||
| Q3 24 | — | $-92.0M | ||
| Q2 24 | — | $-93.0M | ||
| Q1 24 | — | $-4.0M |
毛利率ASPIRCUS
| Q4 25 | 12.5% | — | ||
| Q3 25 | 8.7% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率ASPIRCUS
| Q4 25 | — | -1036.4% | ||
| Q3 25 | -306.1% | -2366.7% | ||
| Q2 25 | — | -100.0% | ||
| Q1 25 | — | -1525.0% | ||
| Q4 24 | — | -447.8% | ||
| Q3 24 | — | -1500.0% | ||
| Q2 24 | — | -963.6% | ||
| Q1 24 | — | -160.0% |
净利率ASPIRCUS
| Q4 25 | — | -963.6% | ||
| Q3 25 | -263.7% | -2250.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -1400.0% | ||
| Q4 24 | — | -408.7% | ||
| Q3 24 | — | -1314.3% | ||
| Q2 24 | — | -845.5% | ||
| Q1 24 | — | -40.0% |
每股收益（稀释后）ASPIRCUS
| Q4 25 | — | $-0.88 | ||
| Q3 25 | $-0.15 | $-1.27 | ||
| Q2 25 | — | $0.00 | ||
| Q1 25 | — | $-1.14 | ||
| Q4 24 | — | $-1.07 | ||
| Q3 24 | — | $-1.00 | ||
| Q2 24 | — | $-1.02 | ||
| Q1 24 | — | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $333.3M | $222.0M |
| 总债务越低越好 | $14.4M | $99.0M |
| 股东权益账面价值 | $204.2M | $631.0M |
| 总资产 | $498.0M | $1.1B |
| 负债/权益比越低杠杆越低 | 0.07× | 0.16× |
8季度趋势，按日历期对齐
现金及短期投资ASPIRCUS
| Q4 25 | $333.3M | $222.0M | ||
| Q3 25 | $113.9M | $238.0M | ||
| Q2 25 | — | $248.0M | ||
| Q1 25 | — | $192.0M | ||
| Q4 24 | — | $150.0M | ||
| Q3 24 | — | $201.0M | ||
| Q2 24 | — | $156.0M | ||
| Q1 24 | — | $185.0M |
总债务ASPIRCUS
| Q4 25 | $14.4M | $99.0M | ||
| Q3 25 | $13.9M | $98.0M | ||
| Q2 25 | — | $97.0M | ||
| Q1 25 | — | $48.0M | ||
| Q4 24 | — | $48.0M | ||
| Q3 24 | — | $47.0M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ASPIRCUS
| Q4 25 | $204.2M | $631.0M | ||
| Q3 25 | $74.1M | $436.0M | ||
| Q2 25 | — | $549.0M | ||
| Q1 25 | — | $531.0M | ||
| Q4 24 | — | $485.0M | ||
| Q3 24 | — | $565.0M | ||
| Q2 24 | — | $635.0M | ||
| Q1 24 | — | $707.0M |
总资产ASPIRCUS
| Q4 25 | $498.0M | $1.1B | ||
| Q3 25 | $225.9M | $974.0M | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | $1.2B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $1.2B | ||
| Q1 24 | — | $1.3B |
负债/权益比ASPIRCUS
| Q4 25 | 0.07× | 0.16× | ||
| Q3 25 | 0.19× | 0.22× | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | 0.10× | ||
| Q3 24 | — | 0.08× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-37.8M | $-120.0M |
| 自由现金流经营现金流 - 资本支出 | $-47.4M | $-121.0M |
| 自由现金流率自由现金流/营收 | -284.7% | -1100.0% |
| 资本支出强度资本支出/营收 | 57.9% | 9.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASPIRCUS
| Q4 25 | $-37.8M | $-120.0M | ||
| Q3 25 | $-8.9M | $-97.0M | ||
| Q2 25 | — | $-133.0M | ||
| Q1 25 | — | $-132.0M | ||
| Q4 24 | — | $-100.0M | ||
| Q3 24 | — | $26.0M | ||
| Q2 24 | — | $-94.0M | ||
| Q1 24 | — | $-2.0M |
自由现金流ASPIRCUS
| Q4 25 | $-47.4M | $-121.0M | ||
| Q3 25 | $-12.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-133.0M | ||
| Q4 24 | — | $-101.0M | ||
| Q3 24 | — | $25.0M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-6.0M |
自由现金流率ASPIRCUS
| Q4 25 | -284.7% | -1100.0% | ||
| Q3 25 | -245.5% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -1662.5% | ||
| Q4 24 | — | -439.1% | ||
| Q3 24 | — | 357.1% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -60.0% |
资本支出强度ASPIRCUS
| Q4 25 | 57.9% | 9.1% | ||
| Q3 25 | 64.4% | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 12.5% | ||
| Q4 24 | — | 4.3% | ||
| Q3 24 | — | 14.3% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 40.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASPI
暂无分部数据
RCUS
| Other | $5.0M | 45% |
| Other Collaboration Revenue | $4.0M | 36% |
| Access Rights And Option Continuation Periods | $2.0M | 18% |
